nach oben

Breast Cancer Research and Treatment

Erschienen in:

01.08.2008 | Letter to the editor

Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors

verfasst von: Hakan Harputluoglu, Omer Dizdar, Fatih Karaahmet, Kadri Altundag

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor, …

Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B (2007) Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat 2007 Aug 3, [Epub ahead of print]

Coleman RE (2000) Management of bone metastases. Oncologist 5:463–470PubMedCrossRef

van Beek E, Pieterman E, Cohen L, Lowik C, Papapoulos S (1999) Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo. Biochem Biophys Res Commun 255:491–494PubMedCrossRef

Powles T, McCloskey E, Kurkilahti M (2004) Oral clodronate for adjuvant treatment of operable breast cancer: results of a randomized, double-blind, placebo-controlled multicenter trial. Fortieth Annual Meeting of American Society of Clinical Oncology, New Orleans, USA, June 5–8, 2004. Proc Am Soc Clin Oncol 22:(abst 528)

Jaschke A, Bastert G, Solomayer EF, Costa S, Schuetz F, Diel IJ (2004) Adjuvant clodronate treatment improves the overall survival of primary breast cancer patients with micrometastases to bone marrow—a longtime follow-up. Fortieth Annual Meeting of American Society of Clinical Oncology, New Orleans, USA, June 5–8, 2004. Proc Am Soc Clin Oncol 22:(abst 529)

Titel: Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors
verfasst von: Hakan Harputluoglu
Omer Dizdar
Fatih Karaahmet
Kadri Altundag
Publikationsdatum: 01.08.2008
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2008
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-007-9735-0

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors

Excerpt

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue

Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers

The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome

Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines

Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria

Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie